洛伐他汀
- 名Lovastatin
-
组为阳性对照组,在B组基础上每日口服洛伐他汀;
C group was positive control group , which was orally administrated Lovastatin per day on base of B group ;
-
HPLC测定洛伐他汀烟酸缓释片中两组分含量
Determination of two components in lovastatin and niacin sustained release tablets by HPLC
-
结论在进行烟酸/洛伐他汀复方缓释整体剂量滴定法的II期临床试验中,控制其病例脱落率较为重要。
Conclusion It is imported that the deciduous rate in the clinical trial phase II was controlled .
-
Monascusruber5031洛伐他汀合成酶基因的PCR分析
PCR analyses of Monascus ruber 5031 monacolin K biosynthetic gene cluster
-
结论UV可用于洛伐他汀缓释片的质量控制和释放度研究。
Conclusion The UV method can be used in the quality control of lovastatin sustained-release tablets .
-
红曲有效成分洛伐他汀对高脂小鼠血脂代谢及脂蛋白脂酶mRNA表达的作用
Effect of Lovastatin from Red Kojic on lipid metabolism and expression of lipoprotein lipase mRNA in hyperlipidemic mice
-
目的探索采用反相高效液相色谱法(HPLC),提高检出血浆洛伐他汀浓度及缩短测定时间。
Objective To improve the detection concentration and time of plasma lovastatin by studying the RP-HPLC method .
-
RP-HPLC测定洛伐他汀及片剂的有关物质
RP-HPLC Determination of the Related Substances of Lovastatin and Its Tablets
-
目的:研究po洛伐他汀胶囊与美降之片后,洛伐他汀在血浆中的药动学与相对生物利用度。
OBJECTIVE : To study the pharmacokinetics and relative bioavailability of lovastatin capsule .
-
RP-HPLC法测定洛伐他汀胶囊及片剂的含量
Determination of Lovastatin in Capsules and Tablets by RP-HPLC
-
RP-HPLC测定洛伐他汀及胶囊的含量
Determination of Lovastatin and Lovastatin capsules by RP-HPLC
-
洛伐他汀对HL-60、KG-1、K562白血病细胞体外作用的研究
Effects of Lovastatin on Leukemia Cells HL-60 , KG-1 , K562 in Vitro
-
方法:临床研究:40例高脂血症患者随机分为2个组,A组(血脂康组),B组(洛伐他汀组)。
Methods : Clinical effect : 40 cases of hyperlipemia patients were divided randomly into 2 groups : Group A ( XZK group ), Group B ( Lovastatin group ) .
-
目的分析Monascusruber5031洛伐他汀合成酶基因的结构。
Objective Analyses the structure of Monascus ruber 5031 lovastatin biosynthesis gene cluster .
-
洛伐他汀和地塞米松对成骨细胞凋亡及Caspase-3活性影响的实验研究
Empirical Study of the Influence of Lovastatin and Dexamethasone on Apoptosis and Activity of Caspase-3 of Osteoblasts
-
洛伐他汀促进成骨细胞增殖、BMP-2表达和矿化的实验研究
Experimental study on lovastatin promoting proliferation , bmp-2 expression and mineralization of osteoblasts
-
洛伐他汀对MCF-7细胞pRb蛋白表达及增殖功能的影响
Effects of Lovastatin on Proliferation Ability and pRb Protein Expression of MCF-7 Cells
-
洛伐他汀低剂量(2mg/kg)与高剂量(4mg/kg)处理组;
Low dose ( 2mg / kg ) and high dose ( 4mg / kg ) of lovastatin-treated group ;
-
洛伐他汀对高糖诱导大鼠近端肾小管上皮细胞钠钾ATP酶活性的影响
Effects of Lovastatin on Na + , K + - ATPase activity of rat proximal tubule epithelial cells under high concentration of glucose
-
洛伐他汀对MCF-7细胞核转录因子和细胞周期调控蛋白表达的影响
Effect of lovastatin on the expression of I κ B α and cell-cycle regulating protein in MCF-7 cells
-
各剂量PSK和洛伐他汀均不能显著降低实验性高脂血症家兔血浆TG水平(P>0.05)。
Neither high dose PSK or lovastatin could recover plasma TC and LDL levels of experimental hyperlipoidemia rabbits to normal .
-
目的:研究洛伐他汀缓释片在Beagle犬体内的药动学特征及其口服相对生物利用度。
AIM : To study the oral correlative bioequivalence and pharmacokinetics of lovastatin sustained release tablets in Beagle dogs .
-
其开环率不低于90%,水相中开环洛伐他汀HPLC含量达到92%。
Under this condition , the percentage of cleaved Lovastatin was more than 90 . Moreover , the content of open-ring Lovastatin in water phase was 92 % detected by HPLC .
-
洛伐他汀对人乳腺癌细胞MDA-MB-231的生长抑制作用及相关机制
Effects of lovastatin on proliferation of human breast cancer cell MDA-MB-231 and its Mechanisms
-
洛伐他汀与Omega-3脂肪酸对老年混合型高脂血症患者的影响
The efficacy of lovastatin and omega-3 fatty acid in treatment of combined hyperlipidemia in old people
-
洛伐他汀对糖尿病大鼠肾功能及肾脏组织p38丝裂原激活蛋白激酶表达的影响
Effects of lovastatin on renal function and expression of phosphorylating - p38 mitogen-activated protein kinase in experimental diabetic nephropathy in rats
-
上述结果提示:HMG-CoA还原酶抑制剂洛伐他汀抑制HL-60细胞内源性胆固醇合成后,能显著抑制细胞增殖,诱导细胞凋亡。
These observations suggest that : lovastatin could inhibit the cellular proliferation and induce apoptosis significantly in HL-60 cells .
-
辛伐他汀、洛伐他汀或阿伐他汀降低血清TC、LDLc以及TG的幅度分别与治疗前相应的基础血脂水平呈正相关。
A positive linear correlation was found between baseline values and effects of simvastatin , lovastatin , or atorvastatin in reducing serum TC , LDL C , and TG , respectively .
-
GGPP能明显逆转洛伐他汀对ADPKD囊肿衬里上皮细胞和间质成纤维细胞I型和W型胶原分泌的抑制作用(尸<0.01)。
GGPP was able to reverse the growth inhibition of lovastatin in ADPKD cyst-lining epithelial cells and fibroblasts .
-
结果洛伐他汀治疗后血TC、LDL-C浓度明显降低,HDL-C浓度升高,差别有非常显著意义(P<0.01),TG则下降不明显(P>0.05);
Results The level of plasma TC and LDL-C decreased obviously and the level of HDL-C was elevated after treatment by Lovastatin ( P < 0.01 ) .